Further medicines added to the list of medicines that cannot be parallel exported from the UK

Further medicines added to the list of medicines that cannot be parallel exported from the UK

April 3, 2020

The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced that an additional 52 medicines have been added to the list of medicines which must not be parallel exported from the UK. The restriction will be in place from 00:00am 01 April 2020.

The new restrictions cover crucial medicines such as:

  • inhalers
  • certain antibiotics
  • codeine

View the latest list of medicines that cannot be parallel exported from the UK (updated 01/04/20)

The list, will continue to be reviewed on an ongoing basis, to include any product that meets the following criteria:

  1. the medicine is required to meet the needs of UK patients;
  2. the medicine is either being parallel exported or is at threat of being parallel exported; and
  3. the export of that medicine is either contributing to, or may contribute to, a shortage of that medicine in the UK.



Posted in: ,


More Latest News >